English
Home > Products > 62211-93-2

China 62211-93-2 Factory

We believe that prolonged expression partnership is really a result of top of the range, value added support, rich encounter and personal contact for 62211-93-2,CAS NO 62211-93-2,Capecitabine intermediate,Capecitabine advance intermediate,1,2,3-Triacetyl-5-deoxy-D-ribose, Welcome any inquiry to our firm. We will be happy to ascertain helpful business enterprise relationships along with you!
62211-93-2, Our technical expertise, customer-friendly service, and specialized products and solutions make us/company name the first choice of customers and vendors. We have been looking for your inquiry. Let's set up the cooperation right now!

Related Products

Hot Products

  • Ledipasvir acetone

    Ledipasvir acetone

    Product Name:Ledipasvir acetone
    Molecular Formula:C52H60F2N8O7
    Molecular Weight;947.1
    CAS Registry Number;1441674-54-9
  • Peramivir

    Peramivir

    Product Name:Peramivir
    Molecular Formula:C15H30N4O5
    Molecular Weight;346.43
    CAS Registry Number;1041434-82-5
  • 2',6'-Pipecoloxylidide

    2',6'-Pipecoloxylidide

    Product Name:2',6'-Pipecoloxylidide
    Molecular Formula:C14H20N2O
    Molecular Weight:232.32
    CAS Registry Number:15883-20-2
  • 2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride

    2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride

    Product Name:2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride
    Molecular Formula:C11H19ClN2O
    Molecular Weight:230.74
    CAS Registry Number:151257-01-1
  • Tubulysin A

    Tubulysin A

    Product Name:Tubulysin A
    Molecular Formula:C43H65N5O10S
    Molecular Weight;844.07
    CAS Registry Number;205304-86-5
  • Salicylic Acid

    Salicylic Acid

    Product Name:Salicylic Acid
    Molecular Weight:138.12
    CAS Registry Number:69-72-7
  • Related Blog
  • Reviews

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 62211-93-2

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept